A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States

• Main Authors: David Fitz-Patrick (Author), Mariano Young Jr (Author), Daniel A. Scott (Author), Ingrid L. Scully (Author), Gary Baugher (Author), Yahong Peng (Author), Kathrin U. Jansen (Author), William Gruber (Author), Wendy Watson (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Expanding serotype coverage of pneumococcal conjugate vaccines (PCVs) to target prevailing disease-causing serotypes could further reduce disease burden. To address this need, 2 different PCVs have been investigated: a 20-valent PCV (PCV20; includes the 13 serotypes in the 13-valent PCV [PCV13] plus...